ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Elon Musk jumps into transgender debate, says prison for parent, doctor who 'sterilizes' a child

Billionaire entrepreneur Elon Musk on Friday tweeted that parents and doctors who put children through transgender medical treatments should "go to prison for life."

Billionaire Elon Musk stirred the pot on Twitter Friday morning with his unfiltered thoughts on what should happen to parents and doctors who put children through transgender medical treatments. 

"Any parent or doctor who sterilizes a child before they are a consenting adult should go to prison for life," Musk tweeted. 

His declaration came in reply to libertarian commentator Josie Glabach, a.k.a. The Redheaded Libertarian, who had shared an MSNBC op-ed that criticized Florida Gov. Ron DeSantis. DeSantis and Republicans across the nation are pushing for legislation that would ban transgender medical treatments for minors, including puberty blockers and sex-reassignment surgeries.

Musk's comments were cheered by Republican lawmakers who oppose permitting gender dysphoric children to undergo transgender medical procedures, which is considered best practice by major medical groups, including the American Medical Association, the Children's Hospital Association and the American Academy of Pediatrics. 

TWITTER TO LET USERS MONETIZE CONTENT WITH SUBSCRIPTIONS

"Why is this a controversial statement?" asked Sen. Ted Cruz, R-Texas.

Populist firebrand Rep. Marjorie Taylor Greene, R-Ga., voiced her agreement with Musk. "That’s why I introduced the Protect Children’s Innocence Act that makes it a felony to perform gender-affirming care on children under the age of 18," she said. 

And Rep. Max Miller, R-Ohio, likened transgender care to "child abuse." 

"Parents and doctors who encourage hormone therapy and surgery are evil, period," Miller tweeted. "Common sense is no longer common." 

There is a national movement led by conservatives that argues hormone replacement therapy, puberty blockers, and sex-reassignment surgeries to be unproven and potentially dangerous to children. At least 14 states have enacted bans on transgender medical treatments for minors, according to the Movement Advancement Project. 

BUD LIGHT BACKLASH COULD HIT BEER SUPPLIES

Those who support legislation banning these treatments for kids say gender-confused kids are being encouraged to make life-altering and permanent decisions before they are able to understand the consequences of doing so. 

Research suggests that regret among transgender individuals who have medically transformed their bodies is rare, but some who have detransitioned, like activist Chloe Cole, have gained prominence in the movement opposing so-called "gender-affirming care" for minors. 

Advocates for transgender people say that such care is life-saving because untreated trans youth face higher rates of depression and suicide. President Biden and his administration have called attempts to deny trans youth recommended medical care discriminatory and cruel. 

BUD LIGHT SUFFERS BLOODBATH AS LONGTIME AND LOYAL CUSTOMERS REVOLT AGAINST TRANSGENDER CAMPAIGN

Opponents counter that the United States is out of step with European countries, including Sweden, Finland and the U.K., which have found that the benefits of puberty blockers and cross-sex hormones are low compared to the risks and have enacted strict eligibility requirements for minors to receive these treatments. 

GET FOX BUSINESS ON THE GO BY CLICKING HERE

The number of transgender teens under 18 doubled between 2017 and 2020, from .7% to 1.4%, according to UCLA research. The report released last June, based on government health surveys, also found that just under 43% of the 1.6 million people who identify as transgender in the U.S. are between 13 and 25.

The Associated Press contributed to this report.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.